Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Single-cell gene expression analyses reveal distinct self-renewing and proliferating subsets in the leukemia stem cell compartment in acute myeloid leukemia.

Sachs K, Sarver AL, Noble-Orcutt KE, LaRue RS, Antony ML, Chang D, Lee Y, Navis CM, Hillesheim AL, Nykaza IR, Ha NA, Hansen CJ, Karadag FK, Bergerson RJ, Verneris MR, Meredith MM, Schomaker ML, Linden MA, Myers CL, Largaespada DA, Sachs Z.

Cancer Res. 2019 Nov 29. pii: canres.2932.2018. doi: 10.1158/0008-5472.CAN-18-2932. [Epub ahead of print]

PMID:
31784425
2.

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.

Depreter B, Weening KE, Vandepoele K, Essand M, De Moerloose B, Themeli M, Cloos J, Hanekamp D, Moors I, D' Hont I, Denys B, Uyttebroeck A, Van Damme A, Dedeken L, Snauwaert S, Goetgeluk G, De Munter S, Kerre T, Vandekerckhove B, Lammens T, Philippé J.

Haematologica. 2019 Aug 1. pii: haematol.2019.222612. doi: 10.3324/haematol.2019.222612. [Epub ahead of print]

3.

Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

Kania G, Rudnik M, Distler O.

Nat Rev Rheumatol. 2019 May;15(5):288-302. doi: 10.1038/s41584-019-0212-z. Review.

PMID:
30953037
4.

Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment.

Urdinguio RG, Lopez V, Bayón GF, Diaz de la Guardia R, Sierra MI, García-Toraño E, Perez RF, García MG, Carella A, Pruneda PC, Prieto C, Dmitrijeva M, Santamarina P, Belmonte T, Mangas C, Diaconu E, Ferrero C, Tejedor JR, Fernandez-Morera JL, Bravo C, Bueno C, Sanjuan-Pla A, Rodriguez RM, Suarez-Alvarez B, López-Larrea C, Bernal T, Colado E, Balbín M, García-Suarez O, Chiara MD, Sáenz-de-Santa-María I, Rodríguez F, Pando-Sandoval A, Rodrigo L, Santos L, Salas A, Vallejo-Díaz J, C Carrera A, Rico D, Hernández-López I, Vayá A, Ricart JM, Seto E, Sima-Teruel N, Vaquero A, Valledor L, Cañal MJ, Pisano D, Graña-Castro O, Thomas T, Voss AK, Menéndez P, Villar-Garea A, Deutzmann R, Fernandez AF, Fraga MF.

Nucleic Acids Res. 2019 Jun 4;47(10):5016-5037. doi: 10.1093/nar/gkz195.

5.

The Myeloid Cell Compartment-Cell by Cell.

Bassler K, Schulte-Schrepping J, Warnat-Herresthal S, Aschenbrenner AC, Schultze JL.

Annu Rev Immunol. 2019 Apr 26;37:269-293. doi: 10.1146/annurev-immunol-042718-041728. Epub 2019 Jan 16.

PMID:
30649988
6.

Effect of Age on NK Cell Compartment in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors.

Rodrigues-Santos P, López-Sejas N, Almeida JS, Ruzičková L, Couceiro P, Alves V, Campos C, Alonso C, Tarazona R, Freitas-Tavares P, Solana R, Santos-Rosa M.

Front Immunol. 2018 Nov 8;9:2587. doi: 10.3389/fimmu.2018.02587. eCollection 2018.

7.

Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.

Culen M, Borsky M, Nemethova V, Razga F, Smejkal J, Jurcek T, Dvorakova D, Zackova D, Weinbergerova B, Semerad L, Sadovnik I, Eisenwort G, Herrmann H, Valent P, Mayer J, Racil Z.

Oncotarget. 2016 May 31;7(22):33016-24. doi: 10.18632/oncotarget.9108.

8.

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity.

Broz ML, Binnewies M, Boldajipour B, Nelson AE, Pollack JL, Erle DJ, Barczak A, Rosenblum MD, Daud A, Barber DL, Amigorena S, Van't Veer LJ, Sperling AI, Wolf DM, Krummel MF.

Cancer Cell. 2014 Dec 8;26(6):938. doi: 10.1016/j.ccell.2014.11.010. Epub 2014 Dec 8. No abstract available.

9.

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

Broz ML, Binnewies M, Boldajipour B, Nelson AE, Pollack JL, Erle DJ, Barczak A, Rosenblum MD, Daud A, Barber DL, Amigorena S, Van't Veer LJ, Sperling AI, Wolf DM, Krummel MF.

Cancer Cell. 2014 Nov 10;26(5):638-52. doi: 10.1016/j.ccell.2014.09.007. Epub 2014 Oct 16.

10.

Targeting the acute myeloid leukemic stem cell compartment by enhancing tumor cell-based vaccines.

Ruben JM, Visser LL, Bontkes HJ, Westers TM, Ossenkoppele GJ, de Gruijl TD, van de Loosdrecht AA.

Immunotherapy. 2013 Aug;5(8):859-68. doi: 10.2217/imt.13.76. Review.

PMID:
23902555
11.

Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia.

Terwijn M, Kelder A, Snel AN, Rutten AP, Scholten WJ, Oussoren YJ, Van De Loosdrecht AA, Zweegman S, Ossenkoppele GJ, Schuurhuis GJ.

Int J Lab Hematol. 2012 Aug;34(4):432-41. doi: 10.1111/j.1751-553X.2012.01416.x. Epub 2012 Apr 4.

PMID:
22471741
12.
13.

Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemia.

Chomel JC, Sorel N, Bonnet ML, Bertrand A, Brizard F, Roy L, Guilhot F, Turhan AG.

Leuk Lymphoma. 2010 Nov;51(11):2103-11. doi: 10.3109/10428194.2010.520774. Epub 2010 Oct 7.

PMID:
20929330
14.

Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment.

Pedranzini L, Mottadelli F, Ronzoni S, Rossella F, Ferracin M, Magnani I, Roversi G, Colapietro P, Negrini M, Pelicci PG, Larizza L.

Leuk Res. 2010 Oct;34(10):1287-95. doi: 10.1016/j.leukres.2010.02.012. Epub 2010 Mar 12.

PMID:
20227111
15.

Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.

van Rhenen A, Moshaver B, Kelder A, Feller N, Nieuwint AW, Zweegman S, Ossenkoppele GJ, Schuurhuis GJ.

Leukemia. 2007 Aug;21(8):1700-7. Epub 2007 May 24.

PMID:
17525725
16.

Complexity of the human acute myeloid leukemia stem cell compartment: implications for therapy.

Dick JE.

Biol Blood Marrow Transplant. 2005 Feb;11(2 Suppl 2):9-11. Review. No abstract available.

18.
19.

Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.

Mehrotra B, George TI, Kavanau K, Avet-Loiseau H, Moore D 2nd, Willman CL, Slovak ML, Atwater S, Head DR, Pallavicini MG.

Blood. 1995 Aug 1;86(3):1139-47.

PMID:
7542497

Supplemental Content

Loading ...
Support Center